Previous 10 | Next 10 |
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company commercializing the CellFX® System Powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today two changes to its ...
Gainers: Data Storage Corporation (DTST) +40%. Indonesia Energy Corporation (INDO) +30%. Harpoon Therapeutics (HARP) +28%. Pulse Biosciences (PLSE) +24%. Praxis Precision Medicines (PRAX) +24%. Xeris Biopharma Holdings (XERS) +24%. Griffon Corporation (GFF) +22%. New Concept Energy (GBR) +20%...
H.C. Wainwright has downgraded shares of Pulse Biosciences (NASDAQ:PLSE) to neutral from buy on concerns of a new strategic initiative to boost utilization of its CellFX skin lesion device at clinics. The firm also removed a price target. Analyst Swayampakula Ramakanth said that management wa...
Pulse Biosciences, Inc. (PLSE) Q1 2022 Earnings Conference Call May 11, 2022 04:30 PM ET Company Participants Philip Taylor - Investor Relations Darrin Uecker - President & Chief Executive Officer Sandra Gardiner - Chief Financial Officer Kevin Danahy - Chief Commercial Officer Conference...
Pulse Biosciences press release (NASDAQ:PLSE): Q1 GAAP EPS of -$0.58 misses by $0.06. Revenue of $0.44M misses by $0.28M. Cash, cash equivalents and investments totaled $12.7 million as of March 31, 2022. For further details see: Pulse Biosciences GAAP EPS of -$0.58 misses by $0.06, rev...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial results for the first quarter of 2022. This press release features multi...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the first quarter of 2022 after market close on W...
Oral podium presentation highlights new long-term clinical results to clear Sebaceous Hyperplasia (SH) with high efficacy, continued improvement and good cosmesis Poster presents successful first case report of NPS procedure for recalcitrant HPV-related dermatosis on the lips ...
Gainers: Vallon Pharmaceuticals (VLON) +80%. Blueknight Energy Partners (BKEP) +38%. Moving iMage Technologies (MITQ) +37%. RISE Education Cayman (REDU) +15%. Sky Harbour Group (SKYH) +14%. GWG Holdings (GWGH) +14%. Evelo Biosciences (EVLO) +13%. Chindata Group Holdings (CD) +13%. Shattuck La...
Gainers: Cyngn (CYN) +70%. Sky Harbour Group (SKYH) +28%. Redbox Entertainment (RDBX) +25%. Wrap Technologies (WRAP) +18%. Inozyme Pharma (INZY) +16%. MedAvail Holdings (MDVL) +14%. Red Cat Holdings (OTCQB:RCAT) +13%. Pulse Biosciences (PLSE) +12%. United Airlines Holdings (UAL) +11%. Alpha T...
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the closing of its rights offering and the fi...
2024-06-25 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...